AAAAAA
Results:
1-19
|
Results: 19
Authors:
McCluskie, MJ
Weeratna, RD
Payette, PJ
Davis, HL
Citation: Mj. Mccluskie et al., The potential of CpG oligodeoxynucleotides as mucosal adjuvants, CR R IMMUN, 21(1-3), 2001, pp. 103-120
Authors:
Payette, PJ
Weeratna, RD
McCluskie, MJ
Davis, HL
Citation: Pj. Payette et al., Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms, GENE THER, 8(18), 2001, pp. 1395-1400
Authors:
Weeratna, RD
Millan, CLB
McCluskie, MJ
Siegrist, CA
Davis, HL
Citation: Rd. Weeratna et al., Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies, FEMS IM MED, 30(3), 2001, pp. 241-247
Authors:
McCluskie, MJ
Weeratna, RD
Clements, JD
Davis, HL
Citation: Mj. Mccluskie et al., Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants, VACCINE, 19(27), 2001, pp. 3759-3768
Authors:
McCluskie, MJ
Weeratna, RD
Davis, HL
Citation: Mj. Mccluskie et al., The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants, VACCINE, 19(17-19), 2001, pp. 2657-2660
Authors:
Gallichan, WS
Woolstencroft, RN
Guarasci, T
McCluskie, MJ
Davis, HL
Rosenthal, KL
Citation: Ws. Gallichan et al., Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in thegenital tract, J IMMUNOL, 166(5), 2001, pp. 3451-3457
Authors:
McCluskie, MJ
Weeratna, RD
Davis, HL
Citation: Mj. Mccluskie et al., Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigendistribution, MOL MED, 6(10), 2000, pp. 867-877
Authors:
McCluskie, MJ
Weeratna, RD
Davis, HL
Citation: Mj. Mccluskie et al., The role of CpG in DNA vaccines, SPR SEM IMM, 22(1-2), 2000, pp. 125-132
Authors:
Weeratna, RD
McCluskie, MJ
Comanita, L
Wu, T
Davis, HL
Citation: Rd. Weeratna et al., Optimization strategies for DNA vaccines, INTERVIROLO, 43(4-6), 2000, pp. 218-226
Authors:
McCluskie, MJ
Weeratna, RD
Krieg, AM
Davis, HL
Citation: Mj. Mccluskie et al., CpG DNA is an effective oral adjuvant to protein antigens in mice, VACCINE, 19(7-8), 2000, pp. 950-957
Authors:
McCluskie, MJ
Davis, HL
Citation: Mj. Mccluskie et Hl. Davis, Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants, VACCINE, 19(4-5), 2000, pp. 413-422
Authors:
Weeratna, RD
McCluskie, MJ
Xu, Y
Davis, HL
Citation: Rd. Weeratna et al., CpG DNA induces stronger immune responses with less toxicity than other adjuvants, VACCINE, 18(17), 2000, pp. 1755-1762
Authors:
McCluskie, MJ
Davis, HL
Citation: Mj. Mccluskie et Hl. Davis, Mucosal immunization with DNA vaccines, METH MOL M, 29, 2000, pp. 287-295
Authors:
McCluskie, MJ
Davis, HL
Citation: Mj. Mccluskie et Hl. Davis, Mucosal immunization with DNA vaccines, MICROBES IN, 1(9), 1999, pp. 685-698
Authors:
Davis, HL
McCluskie, MJ
Citation: Hl. Davis et Mj. Mccluskie, DNA vaccines for viral diseases, MICROBES IN, 1(1), 1999, pp. 7-21
Authors:
McCluskie, MJ
Millan, CLB
Gramzinski, RA
Robinson, HL
Santoro, JC
Fuller, JT
Widera, G
Haynes, JR
Purcell, RH
Davis, HL
Citation: Mj. Mccluskie et al., Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates, MOL MED, 5(5), 1999, pp. 287-300
Authors:
McCluskie, MJ
Davis, HL
Citation: Mj. Mccluskie et Hl. Davis, Novel strategies using DNA for the induction of mucosal immunity, CR R IMMUN, 19(4), 1999, pp. 303-329
Authors:
McCluskie, MJ
Davis, HL
Citation: Mj. Mccluskie et Hl. Davis, CpG DNA as mucosal adjuvant, VACCINE, 18(3-4), 1999, pp. 231-237
Authors:
McCluskie, MJ
Wen, YM
Di, Q
Davis, HL
Citation: Mj. Mccluskie et al., Immunization against hepatitis B virus by mucosal administration of antigen-antibody complexes, VIRAL IMMUN, 11(4), 1998, pp. 245-252
Risultati:
1-19
|